NEWS
The 2025 AD Scientific Index is here—explore updated university and researcher rankings!
New! Young University / Institution Rankings 2025
New! The 2025 Edition of the AD Scientific Index is now live!
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
"Exciting Update! The 2025 Edition of the AD Scientific Index is now live!
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Top Lists
Ana Bosch
Lund University - Lund / Sweden
Others
AD Scientific Index ID: 1408698
Lunds Universitet
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Ana Bosch's MOST POPULAR ARTICLES
1-)
Molecular biology in breast cancer: intrinsic subtypes and signaling pathwaysP Eroles, A Bosch, JA Pérez-Fidalgo, A LluchCancer treatment reviews 38 (6), 698-707, 20128062012
2-)
Triple-negative breast cancer: molecular features, pathogenesis, treatment and current lines of researchA Bosch, P Eroles, R Zaragoza, JR Viña, A LluchCancer treatment reviews 36 (3), 206-215, 20103852010
3-)
PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor–positive breast cancerA Bosch, Z Li, A Bergamaschi, H Ellis, E Toska, A Prat, JJ Tao, DE Spratt, ...Science translational medicine 7 (283), 283ra51-283ra51, 20152902015
4-)
mTORC1 inhibition is required for sensitivity to PI3K p110α inhibitors in PIK3CA-mutant breast cancerM Elkabets, S Vora, D Juric, N Morse, M Mino-Kenudson, T Muranen, ...Science translational medicine 5 (196), 196ra99-196ra99, 20133162013
5-)
Whole-genome sequencing of triple-negative breast cancers in a population-based clinical studyJ Staaf, D Glodzik, A Bosch, J Vallon-Christersson, C Reuterswärd, ...Nature medicine 25 (10), 1526-1533, 20192442019
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept